FindTrial
Sign In

A randomized placebo-controlled study of small dose and short duration Haloperidol prophylaxis for elderly at risk for postoperative delirium.

A randomized placebo-controlled study of small dose and short duration Haloperidol prophylaxis for elderly at risk for postoperative delirium. - RCT study of Haloperidol for postoperative delirium

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000001039
Enrollment
120
Registered
2008-02-18
Start date
2007-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative delirium

Interventions

Haloperidol 2.5mg will administrated with drip infusion for 3 days after operation in the intervention group. No treatment will be applied to the control group. No treatment will be applied to the con

Sponsors

National Hospital for Geriatrics Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The NEECHAM score under 27 points or MMSE under 25 points are distributed to intervention and non-intervention group.

Exclusion criteria

Exclusion criteria: Emergency surgery. Case of having done treatment intervention on the 0th day (that day of operation) of after the operation.

Design outcomes

Primary

MeasureTime frame
Behavioral and psychological disorders assessed with NEECHAM score will purchased from preoperative day to 7 days after operation consecutively.—

Countries

Japan

Contacts

Public ContactHideyuki Hattori

National Hospital for Geriatrics Medicine Department of Psychiatry

0562-46-2311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026